• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Q2

J&J sales top forecast, helped by hepatitis drug

October 14, 2014 By MassDevice Leave a Comment

J&J sales top forecast, helped by hepatitis drug

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2014, Johnson and Johnson, Q2

Nobel Biocare’s Q2 profits double as it fields buyout interest

August 21, 2014 By Brad Perriello Leave a Comment

Nobel Biocare's Q2 profits double as it fields buyout interest

Filed Under: Dental, MassDevice Earnings Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: 2014, Danaher Corp., Dentsply Sirona, Nobel Biocare Holdings AG, Q2

ConvaTec said to explore 2015 sale

August 19, 2014 By Brad Perriello Leave a Comment

ConvaTec said to explore 2015 sale

Filed Under: MassDevice Earnings Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: 2014, 3m, Avista Capital, C.R. Bard, CareFusion Corp., ConvaTec, Nordic Capital, Q2

Medtronic’s Q1 earnings beat The Street on modest sales bump

August 19, 2014 By Brad Perriello Leave a Comment

Medtronic's Q1 earnings beat The Street on modest sales bump

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: 2014, Q2

Diabetes: DexCom’s revenues jump 64% in Q2

August 11, 2014 By Arezu Sarvestani Leave a Comment

Diabetes: DexCom's revenues jump 64% in Q2

Diabetes devices maker DexCom (NSDQ:DXCM) got a lot of love from Wall Street after issuing its latest quarterly report, with DXCM shares gaining 14.5% since last week.

Filed Under: Big Data, Digital Health, MassDevice Earnings Roundup, News Well Tagged With: 2014, Asante Solutions, Dexcom, Q2

EnteroMedics’ losses widen as it chases FDA approval

August 8, 2014 By Arezu Sarvestani Leave a Comment

EnteroMedics losses widen as it chases FDA approval

Minnesota-based EnteroMedics (NSDQ:ETRM) gained modestly this week after announcing its latest financial report, even though the company missed the mark by a penny.

Filed Under: MassDevice Earnings Roundup, Neuromodulation/Neurostimulation, News Well, Wall Street Beat, Weight loss Tagged With: 2014, EnteroMedics Inc., Minnesota, Q2

Strong Q4, $750M buyback give CareFusion a boost

August 8, 2014 By Arezu Sarvestani Leave a Comment

Strong Q2, $750M buyback give CareFusion a boost

CareFusion (NYSE:CFN) posted a stellar 4th-quarter, posting double-digit growth in revenues and earnings and beating Wall Street’s estimates.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: 2014, CareFusion Corp., Q2

Masimo sinks as Q2 misses the mark

August 8, 2014 By Arezu Sarvestani Leave a Comment

Masimo sinks as Q2 misses the mark

California device maker Masimo (NSDQ:MASI) got no Wall Street love this week after announcing results for its most recent quarter.

Filed Under: MassDevice Earnings Roundup, News Well, Patient Monitoring, Wall Street Beat Tagged With: 2014, Masimo, Q2

Baxano: Strong Q2, new patents can’t appease Wall Street

August 8, 2014 By Arezu Sarvestani Leave a Comment

Baxano: Strong Q2, $10M raise, new patents and clinical trial can't appease Wall Street

Baxano Surgical (NSDQ:BAXS) just can’t seem to do right by Wall Street.

Filed Under: MassDevice Earnings Roundup, News Well, Spine, Wall Street Beat Tagged With: 2014, Baxano Surgical, Q2

Thoratec’s new study, $30M buyback can’t stave off Wall Street exodus after dismal Q2

August 7, 2014 By Arezu Sarvestani Leave a Comment

New study, $30M buyback can't save Thoratec from Wall Street exodus after dismal Q2

Circulatory devices maker Thoratec (NSDQ:THOR) took a major hit yesterday as a bleak 2nd-quarter reports and a lowered outlook on the year sent its stock into a nosedive.

Filed Under: MassDevice Earnings Roundup, News Well, Structural Heart, Wall Street Beat Tagged With: 2014, Clinical Trials, Q2, Thoratec Corp.

Struggling Alere plans to shed some skin after rough Q2

August 6, 2014 By Arezu Sarvestani Leave a Comment

Struggling Alere plans to ditch some units

Massachusetts-based device maker Alere (NYSE:ALR) said in its quarterly earnings call that it’ll shed some of its business units in order to reorganize in the wake of a missed quarter.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2014, Alere, Q2

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 18
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS